Meeting
2014 Gastrointestinal Cancers Symposium
Il-8 as an underutilized prognostic factor in metastatic colorectal cancer.
Authors
Manasi S Shah
The University of Texas MD Anderson Cancer Center, Houston, TX
Manasi S Shah , David R. Fogelman , Carrie Daniel-MacDougall , Kanwal Pratap Singh Raghav , John Heymach , Hai T. Tran , Zhi-Qin Jiang , Scott Kopetz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 409)
DOI
10.1200/jco.2014.32.3_suppl.409
Abstract #
409
Poster Bd #
A28
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Circulating IL-8 levels as candidate marker of antiangiogenic therapy for metastatic colorectal cancer.
First Author: Mitsukuni Suenaga
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The prognostic value of C-reactive protein/albumin ratio and platelet-lymphocyte ratio in patients with pancreatic cancer.
First Author: Yang-Chen Shen
Poster
2020 Gastrointestinal Cancers Symposium
Prognostic utility of inflammation biomarkers in a PDAC trial involving the human anti-CTGF antibody pamrevlumab.
First Author: Mark D. Sternlicht
Poster
2019 ASCO Annual Meeting
Development of a baseline prognostic cytokine signature that correlates with nivolumab (NIVO) clearance (CL): Translational pharmacokinetic/pharmacodynamic (PK/PD) analysis in patients with renal cell carcinoma (RCC).
First Author: Rui Wang